Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2010HepatologyOpen Access

Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels†

View Full Paper
Ask AI
Bookmark
Share

Authors

VRVincent RijckborstApple (Israel)BHBettina E. HansenUniversità Cattolica del Sacro CuoreYÇYılmaz ÇakaloğluAmerikan Hastanesi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rijckborst et al. (2010) studied this question.

synapsesocial.com/papers/6a820710319216693bbf60dfhttps://doi.org/10.1002/hep.23722
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Actions of cytokines on the immune response and viral interactions: an overview1996 · 121 citations
  2. 2Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D2005 · 244 citations
  3. 3Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response2006 · 70 citations